Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN).


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
18 05 2022
Historique:
received: 08 02 2022
accepted: 25 04 2022
entrez: 18 5 2022
pubmed: 19 5 2022
medline: 21 5 2022
Statut: epublish

Résumé

Medical nutrition therapy may be associated with clinical outcomes in critically ill patients with prolonged intensive care unit (ICU) stay. We wanted to assess nutrition practices in European intensive care units (ICU) and their importance for clinical outcomes. Prospective multinational cohort study in patients staying in ICU ≥ 5 days with outcome recorded until day 90. Macronutrient intake from enteral and parenteral nutrition and non-nutritional sources during the first 15 days after ICU admission was compared with targets recommended by ESPEN guidelines. We modeled associations between three categories of daily calorie and protein intake (low: < 10 kcal/kg, < 0.8 g/kg; moderate: 10-20 kcal/kg, 0.8-1.2 g/kg, high: > 20 kcal/kg; > 1.2 g/kg) and the time-varying hazard rates of 90-day mortality or successful weaning from invasive mechanical ventilation (IMV). A total of 1172 patients with median [Q1;Q3] APACHE II score of 18.5 [13.0;26.0] were included, and 24% died within 90 days. Median length of ICU stay was 10.0 [7.0;16.0] days, and 74% of patients could be weaned from invasive mechanical ventilation. Patients reached on average 83% [59;107] and 65% [41;91] of ESPEN calorie and protein recommended targets, respectively. Whereas specific reasons for ICU admission (especially respiratory diseases requiring IMV) were associated with higher intakes (estimate 2.43 [95% CI: 1.60;3.25] for calorie intake, 0.14 [0.09;0.20] for protein intake), a lack of nutrition on the preceding day was associated with lower calorie and protein intakes (- 2.74 [- 3.28; - 2.21] and - 0.12 [- 0.15; - 0.09], respectively). Compared to a lower intake, a daily moderate intake was associated with higher probability of successful weaning (for calories: maximum HR 4.59 [95% CI: 1.5;14.09] on day 12; for protein: maximum HR 2.60 [1.09;6.23] on day 12), and with a lower hazard of death (for calories only: minimum HR 0.15, [0.05;0.39] on day 19). There was no evidence that a high calorie or protein intake was associated with further outcome improvements. Calorie intake was mainly provided according to the targets recommended by the active ESPEN guideline, but protein intake was lower. In patients staying in ICU ≥ 5 days, early moderate daily calorie and protein intakes were associated with improved clinical outcomes. Trial registration NCT04143503 , registered on October 25, 2019.

Sections du résumé

BACKGROUND
Medical nutrition therapy may be associated with clinical outcomes in critically ill patients with prolonged intensive care unit (ICU) stay. We wanted to assess nutrition practices in European intensive care units (ICU) and their importance for clinical outcomes.
METHODS
Prospective multinational cohort study in patients staying in ICU ≥ 5 days with outcome recorded until day 90. Macronutrient intake from enteral and parenteral nutrition and non-nutritional sources during the first 15 days after ICU admission was compared with targets recommended by ESPEN guidelines. We modeled associations between three categories of daily calorie and protein intake (low: < 10 kcal/kg, < 0.8 g/kg; moderate: 10-20 kcal/kg, 0.8-1.2 g/kg, high: > 20 kcal/kg; > 1.2 g/kg) and the time-varying hazard rates of 90-day mortality or successful weaning from invasive mechanical ventilation (IMV).
RESULTS
A total of 1172 patients with median [Q1;Q3] APACHE II score of 18.5 [13.0;26.0] were included, and 24% died within 90 days. Median length of ICU stay was 10.0 [7.0;16.0] days, and 74% of patients could be weaned from invasive mechanical ventilation. Patients reached on average 83% [59;107] and 65% [41;91] of ESPEN calorie and protein recommended targets, respectively. Whereas specific reasons for ICU admission (especially respiratory diseases requiring IMV) were associated with higher intakes (estimate 2.43 [95% CI: 1.60;3.25] for calorie intake, 0.14 [0.09;0.20] for protein intake), a lack of nutrition on the preceding day was associated with lower calorie and protein intakes (- 2.74 [- 3.28; - 2.21] and - 0.12 [- 0.15; - 0.09], respectively). Compared to a lower intake, a daily moderate intake was associated with higher probability of successful weaning (for calories: maximum HR 4.59 [95% CI: 1.5;14.09] on day 12; for protein: maximum HR 2.60 [1.09;6.23] on day 12), and with a lower hazard of death (for calories only: minimum HR 0.15, [0.05;0.39] on day 19). There was no evidence that a high calorie or protein intake was associated with further outcome improvements.
CONCLUSIONS
Calorie intake was mainly provided according to the targets recommended by the active ESPEN guideline, but protein intake was lower. In patients staying in ICU ≥ 5 days, early moderate daily calorie and protein intakes were associated with improved clinical outcomes. Trial registration NCT04143503 , registered on October 25, 2019.

Identifiants

pubmed: 35585554
doi: 10.1186/s13054-022-03997-z
pii: 10.1186/s13054-022-03997-z
pmc: PMC9115983
doi:

Banques de données

ClinicalTrials.gov
['NCT04143503']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

143

Informations de copyright

© 2022. The Author(s).

Références

Clin Nutr. 2019 Feb;38(1):48-79
pubmed: 30348463
JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1349-1357
pubmed: 29701877
JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1252-1262
pubmed: 29701878
JPEN J Parenter Enteral Nutr. 2012 Jan;36(1):60-8
pubmed: 22167076
Clin Nutr ESPEN. 2019 Oct;33:220-275
pubmed: 31451265
Crit Care. 2022 Jan 11;26(1):7
pubmed: 35012618
Am J Clin Nutr. 2018 Nov 1;108(5):988-996
pubmed: 30475959
JPEN J Parenter Enteral Nutr. 2021 Jul;45(5):951-960
pubmed: 32776591
Clin Nutr. 2017 Aug;36(4):1122-1129
pubmed: 27637833
N Engl J Med. 2015 Jun 18;372(25):2398-408
pubmed: 25992505
Crit Care Med. 2017 Feb;45(2):156-163
pubmed: 28098623
Crit Care. 2021 Jul 23;25(1):260
pubmed: 34301303
Crit Care Resusc. 2017 Jun;19(2):117-127
pubmed: 28651507
Intensive Care Med. 2017 Nov;43(11):1637-1647
pubmed: 28936712
Crit Care. 2016 Nov 10;20(1):367
pubmed: 27832823
Clin Nutr. 2009 Aug;28(4):387-400
pubmed: 19505748
Am J Clin Nutr. 2019 Mar 1;109(3):535-543
pubmed: 30850837
Clin Nutr. 2015 Aug;34(4):659-66
pubmed: 25086472
Crit Care Med. 1999 Dec;27(12):2684-9
pubmed: 10628610
Crit Care. 2015 Apr 20;19:180
pubmed: 25927829
Intensive Care Med. 2022 Jan;48(1):25-35
pubmed: 34816288
Clin Nutr. 2019 Apr;38(2):660-667
pubmed: 29709380
Nutrients. 2019 Jan 07;11(1):
pubmed: 30621003
Clin Nutr. 2019 Apr;38(2):883-890
pubmed: 29486907
Clin Nutr ESPEN. 2021 Jun;43:104-110
pubmed: 34024501
Clin Nutr. 2021 Apr;40(4):1562-1570
pubmed: 33743292
Lancet. 2013 Feb 2;381(9864):385-93
pubmed: 23218813
Ann Am Thorac Soc. 2016 Jun;13(6):887-93
pubmed: 27015233
Crit Care. 2021 Dec 14;25(1):424
pubmed: 34906215
Am J Clin Nutr. 2016 May;103(5):1197-203
pubmed: 27030535
Intensive Care Med. 2011 Apr;37(4):601-9
pubmed: 21340655
Crit Care. 2018 Jan 23;22(1):12
pubmed: 29361959
Intensive Care Med. 2017 Sep;43(9):1239-1256
pubmed: 28374096
JPEN J Parenter Enteral Nutr. 2015 Mar;39(3):291-300
pubmed: 25078609
Crit Care. 2017 Aug 25;21(1):227
pubmed: 28841885

Auteurs

Martin Matejovic (M)

First Medical Department, Faculty of Medicine in Pilsen, Charles University and University Hospital in Pilsen, Pilsen, Czech Republic.

Olivier Huet (O)

CHRU La Cavale Blanche, Brest, France.

Karolien Dams (K)

Department of Critical Care Medicine, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

Gunnar Elke (G)

Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Clara Vaquerizo Alonso (C)

Department of Intensive Care Medicine, Fuenlabrada University Hospital (Hospital Universitario de Fuenlabrada), Madrid, Spain.

Akos Csomos (A)

MH EK Honvedkorhaz, Budapest, Hungary.

Łukasz J Krzych (ŁJ)

Department of Anesthesiology and Intensive Care, Medical University of Silesia, Katowice, Poland.

Romano Tetamo (R)

Ospedale AUSL Reggio Emilia, Reggio Emilia, Italy.

Zudin Puthucheary (Z)

Barts Health (Royal London) and Queen Mary University of London, London, England, UK.

Olav Rooyackers (O)

Division of Anesthesiology and Intensive Care, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Inga Tjäder (I)

Karolinska University Hospital, Perioperative Medicine and Intensive Care, Huddinge, Stockholm, Sweden.

Helmut Kuechenhoff (H)

Statistisches Beratungslabor, Institut für Statistik Ludwig-Maximilians-Universität München, Munich, Germany.

Wolfgang H Hartl (WH)

Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Klinikum der Universität, Campus Grosshadern, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, Munich, Germany. whartl@med.uni-muenchen.de.

Michael Hiesmayr (M)

Division of Cardiac, Thoracic, Vascular Anesthesia and Intensive Care, and Center for Medical Statistics, Informatics and Intelligent Systems, Medical University Vienna, Spitalgasse 23, Vienna, Austria. michael.hiesmayr@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH